Skip to content
healthcare.dev

FULVESTRANT

NDC 70710-1688, fulvestrant, injection, solution, from Zydus Pharmaceuticals USA Inc..

Product NDC
70710-1688
Status
Listed
Labeler
Zydus Pharmaceuticals USA Inc.
Dosage form
INJECTION, SOLUTION
Route
INTRAMUSCULAR
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215234
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1688 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • FULVESTRANT50 mg/mL

Pharmacologic classes

Estrogen Receptor Antagonist [EPC]; Estrogen Receptor Antagonists [MoA]; Selective Estrogen Receptor Modulators [MoA]

Package NDCNDC-11Package
70710-1688-8707101688082 SYRINGE, GLASS in 1 CARTON (70710-1688-8) / 5 mL in 1 SYRINGE, GLASS (70710-1688-2)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/994edf79-20a5-4e3a-bb35-c4fe3e65acba
  • Medicare Part B payment limits (ASP)

    GET /v1/drugs/asp?ndc=70710-1688

Use it

Look up 70710-1688 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/70710-1688 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 70710-1688. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.